SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-KSB

                Annual Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934
                   For the fiscal year ended December 31, 1999

                         Commission File Number 0-5367
                         D-LANZ DEVELOPMENT GROUP, INC.
                         ------------------------------
             (Exact name of registrant as specified in Its charter)

  DELAWARE                          11-1717709
(State of Incorporation)   (I.R.S. Employer Identification Number)

400 Grove St., Glen Rock, NJ                                        07452
(Address of Principal Executive Office)                           (Zip Code)

Registrant's telephone number, with area code: (201) 445-8862

         Securities registered pursuant to.Section 12(b) of the Act:
                                      None

         Securities registered pursuant to.Section 12(g) of the Act:
                  Common stock of $.001 par value per share

         Indicate  by,  check  mark  whether  the  registrant  (1) has filed all
reports  required to be filed by Section 13 or 15(d) of the Securities  Exchange
Act of 1934 during the preceding  twelve months (or for such shorter period that
the registrant  was required to file such reports),  and (2) has been subject to
such filing requirements for the past 90 days. Yes X No

     Check if there is no disclosure  of  delinquent  filers in response to Item
405 of Regulation S-B in this form, and no disclosure will be contained,  to the
best of Registrant's  knowledge,  in definitive proxy or information  statements
incorporated  by reference  in Part III of this Form 10-KSB or any  amendment to
this Form 10-KSB. X

State Issuer's Revenues for its most recent fiscal year. $-0-

Aggregate market value of the voting stock held by non-affiliates of registrant:
 $584,000.00 as of December 31, 1999

Number of shares outstanding as of December 31, 1999: 11,900,000.

Documents  incorporated by reference:  Exhibits contained in the Form 10-KSB for
the year  ended  December  31,  1992,  and the  entirety  of the Form 8-K  dated
November 3, 1997.

Part I.
Item 1   DESCRIPTION OF BUSINESS

         D-Lanz  Development  Group,  Inc.  and  (hereinafter   referred  to  as
"Registrant",  "D-Lanz",  or  "Company")  commenced  business  activities  as  a
partnership  in 1947 and was  incorporated  on December 5, 1952,  under the name
Osrow Products Company, Inc. Effective December 1, 1972, Osrow Products Company,
Inc.,  a  New  York  Corporation,   merged  into  OSR  Corporation,  a  Delaware
corporation.  OSR was  incorporated  on June 28, 1972. OSR was formed solely for
the purpose of having Osrow Product  Company's  state of  incorporation  changed
from New York to Delaware and its name changed from Osrow Products Company, Inc.
to OSR  Corporation.  On May 17, 1988,  the Company  amended its  certificate of
incorporation,  changing its name to Resort  Connections,  Inc. and changing the
total  authorized  capital stock to 55,000,000  of which  50,000,000  shares are
common  stock  with a par  value of $.001 per share  and  5,000,000  shares  are
preferred  stock with a par value of $.001 per share.  On January 30, 1990,  the
Company  amended its certificate of  incorporation  to change its name to D-Lanz
Development  Group,  Inc., and to change the aggregate number of shares of stock
the Company may issue to 100,000,000 shares of which 50,000,000 are common stock
with a par value of $.001 per share and  50,000,000  shares are preferred  stock
with a par value of $.001 per share.  On May 6, 1988,  the company  restated the
number of common stock  outstanding by reverse  splitting the number of shares 1
for 4 from 6,2205,970 to 1,551,394.

         On September  30, 1997,  the  Registrant  acquired the assets of Health
Technologies  International,  Inc. ("HTI"), a private New Jersey corporation, in
exchange  for  6,448,606  shares  of the  Registrant's  common  stock.  HTI  was
controlled by Roger Fidler, President of the Registrant.

         The  primary  asset  acquired  from  HTI  is an  exclusive  license  to
manufacture,  market  and  sell a breast  abnormality  indicator  in  Chile  and
Singapore. This product, now known as "BreastCare," with FDA marketing clearance
in place,  was  manufactured  in the United  States by HumaScan,  Inc., a NASDAQ
listed  corporation  which  attempted  to  market  "BreastCare."   However,  the
marketing effort failed and HumaScan  discontinued  its efforts.  The Registrant
and HumaScan are unrelated.

         In April, 2000, the Company entered into an acquisition agreement, with
Eweb21,  Inc., a Korean corporation,  whereby control of the Company has changed
to the controlling  shareholders of Eweb21,  Inc. Eweb21, Inc. is a wholly owned
subsidiary of the Company.  Eweb21,  Inc.'s internet  business provides services
under the names Eweb Mail,  Eweb Commerce,  Eweb Wizard and Eweb Find to and for
over 60,000 on line distributors  through offices in London, U.K., Seoul, Korea,
Tokyo, Japan and Sydney, Australia.

         The Company  transferred  the  "BreastCare"  related  assets to another
wholly  owned  subsidiary,  Global  Agri-Med  Technologies,  Inc.  which it will
spin-off to its shareholders.

     Registrant's  principal  executive offices are at 400 Grove St., Glen Rock,
NJ 07452. Telephone (201) 445-8862.

Item 2.  DESCRIPTION OF PROPERTY

         For the year ending December 31, 1999, The Company's President provided
the Company  with  limited  office  space in his offices at $250 per month.  The
Company's wholly owned subsidiary Eweb21, Inc. maintains offices in Seoul, Korea
and London, England.

Item 3.  LEGAL PROCEEDINGS

         There are no material pending legal actions involving the Company.

Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         Registrant  submitted  no  matters  to a vote of its  security  holders
during its fiscal year ended December 31, 1999.


Part II.
Item 5.  MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

(a)  The  company's  Common  Stock did not trade from 1988 to  February of 1998.
     Currently,  the  Company's  Common  Stock is traded over the counter on the
     Bulletin  Board.  Since that time it has had a high of $1.25,  and a low of
     $0.25. (See Table)

                           HIGH             LOW
         1998
1ST Quarter                $1.00            $0.25
2ND Quarter                 0.56             0.19
3RD Quarter                 0.75             0.25
4TH Quarter                 1.19             0.24

         1999
1ST Quarter                $0.49            $0.16
2ND Quarter                 0.22             0.16
3RD Quarter                 0.16             0.075
4TH Quarter                 0.10             0.075

     The recent bid price of the common stock, after the 1 for 100 reverse split
was $12.50 on May 3, 2000.  The  Company's  stock is traded on the OTC  Bulletin
Board with the symbol DLAN.

(b)  As of  December  31,  1999,  there were  approximately  900  holders of the
     Company's Common Stock.

(c)  No dividends were paid during the fiscal year ending Dec. 31, 1999.

Item 6. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS OR PLAN OF OPERATION



         The Company was formed on June 28, 1972, under the laws of the State of
Delaware to engage in any lawful act or activity for which  corporations  may be
organized  under the  business  corporation  law of the State of  Delaware.  The
Company's principal assets during 1999 consisted of a license to manufacture and
market certain patented technology for the countries of Chile and Singapore. The
product to be produced  under this license is a diagnostic  temperature  sensing
device to screen the breast for abnormalities,  including cancer.  Subsequent to
the end of the 1999  fiscal  year,  the  Company  transferred  the  "BreastCare"
related assets to a subsidiary which it will "spin off" to its shareholders.

         The Company has acquired a new business,  Eweb21,  Inc. Eweb21,  Inc.'s
internet  business  provides  services under the names Eweb Mail, Eweb Commerce,
Eweb  Wizard and Eweb Find to and for over 60,000 on line  distributors  through
offices in London, U.K., Seoul, Korea, Tokyo, Japan and Sydney, Australia.



         Development stage activities.



         The following  discussion  relates to the results of our  operations to
date, and our financial condition:



         For the next 12 months, the Company plans to devote the majority of its
efforts to (i) obtaining financing to expand Eweb21 Inc.'s distributor base, and
(ii) pursue the acquisition of necessary personnel and assets needed to continue
that expansion.



         The Company anticipates that with the completion of a private placement
offering,  the  Company  will be able to  expand  its  operations.  The  Company
anticipates  that its results of operations  may  fluctuate for the  foreseeable
future due to several  factors,  including the timing of the introduction of the
Company's  products into its target  markets;  whether and when new products are
successfully  developed  by the  Company,  market  acceptance  of current or new
products, competitive pressures on pricing, changes in the mix of products sold.
Operating  results would also be adversely  affected by a downturn in the market
for current technology if improved technology is introduced. Because the Company
is continuing to increase its operating expenses for personnel and other general
and administrative  expenses, the Company's operating results would be adversely
affected if its sales did not  correspondingly  increase.  The Company's limited
operating  history  makes  accurate   prediction  of  future  operating  results
difficult or impossible.



         The  Company  has  been  a  development   stage  enterprise  since  its
inception,  June 28, 1972, to December 31, 1999. During this period,  management
had devoted the  majority of its  efforts to  obtaining  the License  agreement,
obtaining preliminary financing,  enhancing its sources for inventory,  pursuing
and  finding a  management  team to  continue  the  process  of  completing  its
marketing  goals,  obtain  sufficient  working  capital through loans and equity
through  a private  placement  offering.  These  activities  were  funded by the
Company's management and investments from stockholders and officer loans.



         Results of Operations



         For the year ended  December  31,  1999 as  compared  to the year ended
December 31, 1998



         The company has remained inoperative. Sales, costs of goods sold, gross
profit,  operating  expenses  and net  profit  were $-0- for both the year ended
December 31, 1998 and 1999.  The activities of the Company during the year ended
December 31, 1998 and 1999  consisted of preparing and filing  corporate  income
tax returns and filings for the Securities and Exchange Commission.



         The Company's general and administrative costs aggregated approximately
$282,472  for the year ended  December  31, 1999 as compared to $986,002 for the
year  ended  December  31,  1998  representing  an  decrease  of  $703,530.  The
accumulated  costs for the year  ended  December  31,  1999  represents  rent of
$3,000,  Salary of $9,000,  bank  charges of $48,  office  expense of $1,924 and
consulting fees of $40,000 paid in shares of common stock.



         Liquidity And Capital Resources



         As of  December  31,  1999,  the  Company's  cash  balance was $352 and
working  capital was  negative at $40,398  consisting  of cash of $384,  Accrued
liabilities of $18,000 and an officer loan of $22,750.



         Net (loss) from  operations  amounted to $(282,472)  for the year ended
December  31,  1999 due to  increases  general and  administrative  expenditures
related to the payment of consulting fees.



         The Company's primary short-term needs are to develop its manufacturing
capabilities,  increase  inventory  levels,  begin to support its  research  and
development  programs and begin  marketing  quantities  of Licensed  devices and
payment of royalty fees.  The Company  currently  plans to expend  approximately
$1.0 million for the expansion and development of its  manufacturing  facilities
in addition to its marketing and general administrative programs.



         The Company expects its capital  requirements to increase over the next
several years as it expands its research and  development  efforts,  new product
development, sales and administrative infrastructure, manufacturing capabilities
and facilities.  The Company's future liquidity and capital funding requirements
will depend on numerous  factors,  including  the extent to which the  Company's
products  under   development  are   successfully   developed  and  gain  market
acceptance,  the timing of regulatory actions regarding the Company's  potential
products,  the costs and timing of  expansion  of sales,  marketing  activities,
facilities expansion needs and procurement.



         The Company  believes that it must raise  additional cash and cash from
operations  to  satisfy  its  funding  needs  for at least  the next 12  months.
Thereafter,  if cash generated from  operations is  insufficient  to satisfy the
Company's working capital and capital expenditure requirements,  the Company may
be required to sell additional  equity or debt  securities or obtain  additional
credit facilities.  There can be no assurance that such financing,  if required,
will be available on satisfactory terms, if at all.



         Income  tax:  As of  December  31,  1999,  the  Company  had a tax loss
carry-forward  of  $1,269,949.  The Company's  ability to utilize its tax credit
carry-forwards in future years will be subject to an annual limitation  pursuant
to the "Change in  Ownership  Rules" under  Section 382 of the Internal  Revenue
Code of 1986, as amended. However, any annual limitation is not expected to have
a material  adverse  effect on the  Company's  ability to utilize its tax credit
carry-forwards.



         Year 2000 Readiness



     The  following  disclosure  is a Year  2000  ("Y2K")  readiness  disclosure
statement pursuant to the Year 2000 Readiness and Disclosure Act.



         The Company's Year 2000 program is designed to minimize the possibility
of serious  Year 2000  interruption.  Possible  Year 2000  worst case  scenarios
include the  interruption  of significant  parts of the Company's  business as a
result of  internal  business  system  failure or the  failure  of the  business
systems of its suppliers, distributors or customers. The potential effect to the
operations of the present business are minimized currently because the Company's
reliance upon computer systems in the day to day operations is minimal.



         However,  the Company  decided to  significantly  upgrade its "business
systems"  (all  computer  hardware  and  software  used  to run  its  businesses
including its  operations  management,  administration  and financial  systems).
Specifications  were  developed for desired  capabilities,  including  Year 2000
compliance.  In 1998 the Company  began  assessing  its Year 2000  exposure  and
commenced implementation of a plan to achieve Year 2000 readiness.  Based on its
review to date, the Company believes that its products and business software are
Year 2000 compliant.



         The Company has also begun to survey major suppliers, distributors, and
customers to determine  the status and schedule for their Year 2000  compliance.
To date,  no  significant  issues  have  been  identified,  and the  survey  was
completed  as of  December  31,  1999.  Where  it  believes  that  a  particular
supplier's  situation poses unacceptable risks, the Company plans to identify an
alternative source.



         The  costs  of  the  readiness  program  for  business  systems,  other
infrastructure  areas,  and suppliers are a combination of incremental  external
spending and use of existing internal  resources.  In total, the Company expects
to spend less than  $1,000 to  achieve  readiness.  This  amount is based on the
costs to upgrade the existing business systems to Y2K compliant versions.



         Milestones and implementation dates and the costs of the Company's Year
2000 readiness program are subject to change based on new circumstances that may
arise or new  information  becoming  available  that may change  the  underlying
assumptions or requirements.

ITEM 7.  FINANCIAL STATEMENTS

The financial statements are attached hereto at page 12.

ITEM 8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
         FINANCIAL DISCLOSURE

The Company did not change accountants for the fiscal year ending 1999.

Part III.

ITEM 9.  DIRECTORS,   EXECUTIVE  OFFICERS,  PROMOTERS  AND  CONTROL  PERSONS  OF
         REGISTRANT

Name                       Age              Position

Roger Fidler               49               President, Chief Financial
                                            Officer and Sole Director

Jay Hait                   30               Secretary


Roger Fidler. Mr. Fidler has been the sole director,  President, Chief Executive
and Financial Officer of the Company since September,  1989. He will serve until
the next annual meeting scheduled for May, or until his successor is elected and
qualified.  Mr.  Fidler has been  engaged in the  private  practice of law since
1983.  Mr. Fidler has also been President of PPA  Technologies,  Inc., a private
specialty  chemicals  company since its  inception in 1994.  Mr. Fidler has also
been President of Health  Technologies  International,  Inc., a private  medical
device company, since 1994.

Jay Hait. Mr. Hait has served as Secretary of the  corporation  since  November,
1997 and will  continue to serve until his  successor is elected and  qualified.
Mr. Hait has worked as an attorney in Mr.  Fidler's  law  practice  since May of
1997. Prior to that, Mr. Hait had been employed as a computer programmer at Isis
Corporation  of  Oakland,  NJ from 1994.  Mr. Hait worked as a help desk and LAN
technician at MDY Advanced  Technologies of Fair Lawn, NJ in 1993, and Viacom of
New York, NY in 1992.


ITEM 10. EXECUTIVE COMPENSATION

         Roger  Fidler,  President,  receives  a salary  of $500 per  month.  No
compensation was paid to any other officer or director of the Company during the
fiscal year ending December 31, 1999.


<TABLE>
<CAPTION>


                            Summary Compensation Table


                   Fiscal                  Annual  Compensation       Long Term
Name & Position    Year      Salary        Bonus    Other(1)       Compensation
<S>                          <C>             <C>         <C>           <C>
Roger Fidler       Current   $6,000          -0-         -0-           -0-
 President          1998     $6,000          -0-         -0-           -0-
                    1997     -0-             -0-         -0-           -0-
                    1996     -0-             -0-         -0-           -0-

</TABLE>

<PAGE>


                            STOCK OPTION INFORMATION

There are no options outstanding.

     The  transactions  between  officers  and  directors of the Company and the
Company and its  affiliates  are made on terms no less  favorable  to the Issuer
than those available from  unaffiliated  parties.  Future  transactions  will be
handled in the same fashion.


<PAGE>





Item 11. SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS

         The  following  table  sets forth  certain  information  regarding  the
beneficial  ownership of the Company's  Common Stock as of December 31, 1999, of
each  officer or director of the  Company,  by each person or firm who owns more
than 5% of the Company's outstanding shares and by all officers and directors of
the Company as a group.



                                    Number of                 Percentage
Name                                Shares                    of shares
                                    Owned                     owned

Roger                               6,060,000                 50.9%
Fidler
400 Grove St.
Glen Rock, NJ 07452

Scantek Medical, Inc.               2,000,000                 16.8%
321 Palmer Rd.
Denville, NJ 07834

Officers and
Directors as
a Group(2 persons)                  6,060,000                 50.9%


Item 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

On September 30, 1997, the Registrant acquired the assets of Health Technologies
International,  Inc. ("HTI"), a private New Jersey corporation,  in exchange for
8,448,606  shares of the  Registrant's  common  stock.  The primary  asset is an
exclusive license to manufacture, market and sell a breast abnormality indicator
in Chile and  Singapore.  HTI was a closely held  corporation  controlled by Mr.
Fidler, who owned 93% of HTI's common stock. Scantek Medical,  Inc. received its
2,000,000 shares pursuant to the terms of the license agreement.


Item 13. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES AND REPORTS ON FORM 8-K

                  (a) All required exhibits are incorporated herein by reference
from the Company's Form 10-KSB filed for the year ending December 31, 1992.

                  (b)  Form  8-k  and  its  associated   schedules  and  reports
reflecting  the purchase of assets from HTI on  September  31, 1997 was filed in
November 3, 1997, and is incorporated by reference.



<PAGE>


                                THOMAS P. MONAHAN
                           CERTIFIED PUBLIC ACCOUNTANT
                              208 LEXINGTON AVENUE
                           PATERSON, NEW JERSEY 07502
                                 (973) 790-8775
                               Fax (973) 790-8845


To The Board of Directors and Shareholders
of  D-Lanz Development Group, Inc.  (a development stage company)

I have audited the accompanying  balance sheet of D-Lanz Development Group, Inc.
(a development stage company) as of December 31, 1999 and the related statements
of operations,  cash flows and shareholders' equity for the years ended December
31, 1998 and 1999.  These  financial  statements are the  responsibility  of the
Company's  management.  My  responsibility  is to  express  an  opinion on these
financial statements based on my audit.

       I conducted  my audit in  accordance  with  generally  accepted  auditing
standards.  Those standards  require that I plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining on a test basis,  evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing  the  accounting   principles  and   significant   estimates  made  by
management,  as well as evaluating the overall financial statement presentation.
I believe that my audit provides a reasonable basis for my opinion.

       In my opinion, the financial statements referred to above present fairly,
in all material  respects,  the financial  position of D-Lanz Development Group,
Inc. (a  development  stage  company) as of December 31, 1999 and the results of
its operations,  shareholders equity and cash flows for the years ended December
31, 1998 and 1999 in conformity with generally accepted accounting principles.

         The accompanying  financial statements have been prepared assuming that
D-Lanz  Development Group, Inc. (a development stage company) will continue as a
going  concern.  As more fully  described  in Note 2, the Company  has  incurred
operating  losses  since  the date of  reorganization  and  requires  additional
capital to continue  operations.  These conditions raise substantial doubt about
the Company's ability to continue as a going concern.  Management's  plans as to
these matters are  described in Note 2. The financial  statements do not include
any  adjustments  to reflect  the  possible  effects on the  recoverability  and
classification of assets or the amounts and  classifications of liabilities that
may result from the possible  inability  of D-Lanz  Development  Group,  Inc. (a
development stage company) to continue as a going concern.


                                                  /s/ Thomas P. Monahan
                                                     Thomas P. Monahan, CPA
April 10, 2000
Paterson, New Jersey






                                 See accompanying notes to financial statements.




<PAGE>



<TABLE>
<CAPTION>


                                       D-LANZ DEVELOPMENT GROUP, INC.

                                        (a development stage company)
                                             BALANCE SHEET
                                          DECEMBER 31, 1999

                                       Assets
Current assets
<S>                                                                                               <C>
  Cash                                                                                            $352
  Total current assets                                                                             352


Other assets
  License agreement                                                                           252,500
                                                                                              -------
Total other assets                                                                            252,500
                                                                                              -------
Total assets                                                                                 $252,852
                                                                                             ========



                                 Liabilities and Stockholders' Equity

Current liabilities
  Accounts payable and accrued expenses                                                        $18,000
  Officer loan payable                                                                          22,750
                                                                                                ------
  Total current liabilities                                                                     40,750


Stockholders' equity
  Common Stock authorized 50,000,000 shares, $0.001  par value each. At  December               11,900
31, 1999, there are 11,900,000 shares outstanding

  Preferred  stock  authorized  50,000,000  shares  $0.001  par Value  each.  At
December 31, 1999, the number of shares outstanding was -0-

  Additional paid in capital                                                                 1,470,151
Deficit accumulated during the development stage                                            (1,269,94)
                                                                                            ----------
Total stockholders' equity                                                                    212,102
                                                                                              -------
Total liabilities and stockholders' equity                                                   $252,852
                                                                                             ========
</TABLE>

                        See accompanying notes to financial statements.

<PAGE>


<TABLE>
<CAPTION>


                                    D-LANZ DEVELOPMENT GROUP, INC.

                                     (a development stage company)
                                      STATEMENT OF OPERATIONS
                                                                               For the period
                                               For the          For the       from inception ,
                                              year ended       year ended     June 7, 1985, to
                                             December 31,     December 31,      December 31,
                                                 1998             1999               1999
<S>                                                    <C>              <C>                 <C>
Revenue                                                $-0-             $-0-                $-0-

Costs of goods sold                                     -0-              -0-                 -0-

Gross profit                                            -0-              -0-                 -0-

Operations:
  General and administrative                         28,502          242,472             273,591
  Non cash expenses-consulting fees                 957,500           40,000             997,500
  Depreciation and  amortization                        -0-              -0-                 -0-
                                                     ------           ------              ---
  Total expense                                     986,002          282,472           1,271,091

Loss  from operations                             (986,002)        (282,472)         (1,271,091)


Other income
  Interest income                                    1,142                                1,142
                                                     ------                               -----
Total other income                                   1,142                                1,142

Net income (loss)                                $(984,860)       $(282,472)        $(1,269,949)
                                                 ==========       ==========        ============

Net income (loss)  per share -basic                 $(0.09)        $(0.02)               $(0.11)
                                                    =======        =========             =======
Number of shares outstanding-basic              10,733,333       11,883,333           11,883,333
                                                ===========      ===========          ==========


</TABLE>

                           See accompanying notes to financial statements.

<PAGE>
<TABLE>
<CAPTION>

                                               D-LANZ DEVELOPMENT GROUP, INC.
                                               (a development stage company)
                                               STATEMENT OF CASH FLOWS
                                                                                                    For the period
                                                                    For the          For the       from inception ,
                                                                   year ended       year ended     June 7, 1985, to
                                                                  December 31,     December 31,      December 31,
                                                                      1998             1999               1999
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                   <C>              <C>               <C>
  Net income (loss)                                                   $(984,860)       $(282,472)        $(1,269,949)

       Adjustments to reconcile net loss to cash used in
operating activities
  Depreciation                                                               -0-              -0-                 -0-
  Non cash expenses - consulting fees                                    957,500           40,000             997,500
  Bad debt write off                                                   (371,500)                            (371,500)
  Accounts payable and accrued expenses                                   9,000            9,000              18,000
                                                                          ------           ------             ------
TOTAL CASH FLOWS FROM OPERATIONS                                       (389,860)        (233,472)           (625,949)

CASH FLOWS FROM FINANCING ACTIVITIES
  Officer loan payable                                                    19,000            3,750              22,750
  Sale of common stock                                                   600,000                              603,551
                                                                         -------         ---------            -------
TOTAL CASH FLOWS FROM FINANCING ACTIVITIES                               619,000            3,750             626,301

CASH FLOWS FROM INVESTING ACTIVITIES
  Note receivable                                                      (229,642)         229,642
                                                                       ---------         -------
TOTAL CASH FLOWS FROM INVESTING ACTIVITIES                             (229,642)          229,642

NET INCREASE (DECREASE) IN CASH                                            (502)             (80)                 352
CASH BALANCE BEGINNING OF PERIOD                                            934              432                  -0-
                                                                            ----             ----                 ---
CASH BALANCE END OF PERIOD                                                 $432             $352                 $352
                                                                           =====            =====                =====


                 See accompanying notes to financial statements.
</TABLE>


<PAGE>

<TABLE>
<CAPTION>

                         D-LANZ DEVELOPMENT GROUP, INC.
                        STATEMENT OF STOCKHOLDERS' EQUITY


                                                                                                               Deficit
                            Preferred       Preferred     Common Stock    Common Stock    Additional      accumulated during
Date                          Stock           Stock                                     paid in capital    developent stage    Total
----                          -----           -----                                     ---------------    ----------------    -----
<S>     <C> <C> <C>                <C>          <C>           <C>               <C>              <C>         <C>            <C>
Balance 12- 31- 1991              -0-          -0-            1,551,394         $1,551          -0-          $(1,551)       $-0-
                                  =======      ===            ==========        =======         =======      ========       ====
Balance 12- 31- 1992              -0-          -0-            1,551,394          1,551          -0-            1,551        $-0-
                                  =======      ===            ==========         ======         =======        ======       ====
Balance 12- 31- 1993              -0-          -0-            1,551,394          1,551          -0-            1,551        $-0-
                                  =======      ===            ==========         ======         =======        ======       ====
Balance 12- 31- 1994              -0-          -0-            1,551,394          1,551          -0-            1,551        $-0-
                                  =======      ===            ==========         ======         =======        ======       ====
Balance 12- 31- 1995              -0-          -0-            1,551,394         $1,551          -0-          $(1,551)       $-0-
                                  =======      ===            ==========        =======         =======      ========       ====
Balance 12- 31- 1996                  -0-      -0-             1,551,394         $1,551             -0-      $(1,551)         $-0-
Sale of shares                                                 2,000,000          2,000                                      2,000
Issuance of shares for                                         6,448,606         $6,449        $246,051                   $252,500
acquisition of license
right
Loss 12-31-1997                                                                                               (1,066)      (1,066)
                         --------         -------------                  -------------------------------      -------      -------


Balance 12-31-1997                    -0-      $-0-           10,000,000        $10,000        $246,051       (2,617)     $253,434
Issuance of shares for                                         1,100,000          1,100         584,900                   $586,000
consulting fees
Sales of shares                                                  600,000            600         599,400                    600,000
Loss 12-31-1998                                                                                             (984,860)    (984,860)
                         --------         -------------                  -------------------------------    ---------    ---------


Balance 12-31-1998                    -0-      $-0-           11,700,000        $11,700      $1,430,351    $(987,477)     $454,574
Isuance of shares for                                            200,000            200          39,800                     40,000
consulting fees
Loss 12-31-1999                                                                                             (282,472)    (282,472)
                         --------         -------------                  -------------------------------    ---------    ---------


Balance 12-31-1999                  -0-       $-0-           11,900,000        $11,900      $1,470,151    $1,269,949     $212,102
                                    =====     =====          ===========       ========     ===========   ===========    ========




                 See accompanying notes to financial statements.

</TABLE>


<PAGE>





         Note 1 -  Organization of Company and Issuance of Common Stock



         a. Creation of the Company



         D-Lanz  Development  Group, Inc. (the "Company") was formed on June 28,
1972 under the laws of the State of Delaware under the name OSR Corporation.  On
May 17, 1988, the Company amended its certificate of incorporation  changing its
name to Resort  Connections,  Inc. and changing the total shares  authorized  to
issue to 55,000,000 of which 50,000,000 shares are shares of common stock, $.001
par value per share and 5,000,000 shares of preferred stock, $.001 par value per
share. On January 30, 1990, the Company amended its certificate of incorporation
to change its name to D-Lanz  Development  Group,  Inc. and change the aggregate
number of shares of stock the Company may issue to  100,000,000  shares of which
50,000,000 are shares of common stock,  $.001 par value per share and 50,000,000
shares preferred stock, $.001 par value per share.



         b. Description of the Company



         The  Company  has  purchased  the  License  rights to certain  patented
technology to manufacture  and market for the countries of Chile and Singapore a
temperature  sensing device and  diagnostic  direct  reading,  digital device to
screen the breast for abnormalities, including cancer.



         Note 2 - Summary of Significant Accounting Policies



         a. Basis of Financial Statement Presentation



         The  accompanying  financial  statements  have been prepared on a going
concern basis, which contemplates the realization of assets and the satisfaction
of  liabilities  in the normal course of business.  The Company has been dormant
since December 31, 1990. On September 30, 1997, the Company acquired the License
rights to certain patents. The Company has not generated any income and has been
dependent  upon  management  to pay  the  expenses  to  maintain  the  Company's
existence  and pay the costs of  acquiring  the License  rights.  These  factors
indicate that the Company's  continuation  as a going concern is dependent  upon
its ability to obtain adequate financing.



         The financial  statements presented at December 31, 1999 consist of the
balance sheet of the Company as at December 31, 1999, and the related statements
of operations,  retained earnings and cash flows for the year ended December 31,
1998 and 1999.



         b. Cash and cash equivalents



         The Company treats  temporary  investments with a maturity of less than
three months as cash when purchased as cash.







         c. Significant Concentration of Credit Risk



                At December 31, 1999,  the Company has  concentrated  its credit
risk by maintaining  deposits in several banks. The maximum loss that could have
resulted from this risk totaled $-0- and $-0- which represents the excess of the
deposit liabilities  reported by the banks over the amounts that would have been
covered by the federal insurance.



         d. Earnings per share



         Basic  earnings per share are  calculated  on the basis of the weighted
average number of common shares outstanding for each period.





                 Year ended             Year ended
               December 31, 1998     December 31, 1999

               Weighted number common shares outstanding

               3,663,545             10,733,332



         e. Revenue recognition



      Revenue is recognized when  products are shipped or services are rendered



         f. Use  of Estimates



         The  preparation of financial  statements in conformity  with generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that  effect the  reported  amounts of assets and  liabilities  and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting period. Actual results could differ from those estimates.



         Note 3 -  Acquisition of License Rights



         On September 30, 1997,  the Company issued  6,448,606  shares of common
stock to purchase from Health Technologies  International,  Inc. ("Health Tech")
the rights to manufacture and market certain patented technologies.  The License
has been valued at the historic cash  purchase  price of $252,500 paid by Health
Tech for the manufacturing and marketing rights.



         Health Tech entered into an agreement on August 15, 1996 with  Scantek,
a Delaware  corporation  located in Mountain Lakes, New Jersey for the licensing
of certain  patented  technology to manufacture  and market for the countries of
Chile and Singapore.  The patented  technology consists of a temperature sensing
device and diagnostic  direct  reading,  digital device to screen the breast for
abnormalities, including cancer.



         As a  result  of the  acquisition,  the  Company  has been  granted  an
indivisible,  exclusive  right and license  within the  territories of Chile and
Singapore  to  assemble,  use and sell the devices for a period  ending with the
expiration of the applicable patents in these countries.



         If the Company fails to achieve for a period of 12  consecutive  months
the minimum net sales of the devices with respect to each  country,  Scantek may
upon 30 days written notice and at its option either terminate this agreement or
delete the country from the Company's territories.  Minimum net sales as defined
is based upon  market  penetration.  The size of the market in each of the three
countries will be computed using official  government  census  information  from
each country. The market is defined as the lesser of two pairs of the device for
each women between the ages of 25 and 70 or such usage as may be  recommended by
the relevant  medical  association  or government  agency in each country in the
Territory.



          The percentage of market penetration by year is as follows:

          Year                     Percentage of

                                    Market Penetration

         1998                               0%

         1999                               1%

         2000                               3%

         2001                               4%

         2002 and after                     5%



         This  schedule is based upon the scheduled  delivery of an  operational
assembly line,  part of which will be installed in Scantek's  facility,  part of
which will be install in the Company's facility. The above referenced years were
adjusted to appropriate  calendar years so as not to prejudice the Company's 365
day time period in which to achieve the graduated market penetration.



         As  of  September  30,  1997,   Health  Tech  has  paid  to  Scantek  a
nonrefundable License Fees aggregating $252,500.



         The Company is  required to pay a royalty  equal to 15% of Net Sales of
Licensed Devices in the Territories during each contract year during the term of
the agreement. The royalty paid, will in no instance be less than $1.00 per unit
or a guaranteed minimum royalty payable as follows:



     The first minimum  royalty payment of $80,000 is not due until December 31,
1998;  $200,000  for the year 1999;  $300,000 for the year 2000 and $400,000 for
each year thereafter.



     Royalties are due and payable each quarter either for the actual amount due
or 25% of the minimum royalty payable for the year.



     In the  event  that at any  time  during  the term of this  agreement,  the
consumer price index in effect for the national government of the country of the
territory  be  increased  by 10%  over  the  index  base  as of the  date of the
agreement.  Then the minimum  royalty  payable and the minimum net sales for the
year will be increased by 10%.



         The  Company  sold  to  Scantek   2,000,000  shares  of  common  stock,
representing  20% of the  total  issued  and  outstanding  common  shares of the
Company as of the date of the agreement for the aggregate sum of $2,000 or $.001
per share.  Under no  circumstances  will  Scantek's  common  stock  position be
diluted  to less than 15% of the  issued  and  outstanding  common  stock of the
Company.  In the event  Scantek  will  receive,  at nominal  cost,  warrants  to
purchase  sufficient shares of common stock to maintain its 20% ownership,  such
warrants  will  allow the  purchase  of shares at $2.25 per share for five years
from the date of the agreement.



         The Company is required to arrange to purchase a turnkey  manufacturing
line. Upon  completion of the line,  that portion of the line that  manufactures
Sensors for the  licensed  devices  will be  installed  at the same  location as
Scantek's own manufacturing  facility.  Scantek will operate that portion of the
line and to the extent of the lines manufacturing capacity, deliver the







         Company's  requirements  for Sensors to the  Company's  plant  location
F.O.B.  for cost plus 25%.  Scantek  will  maintain  a purchase  money  security
interest in the sensors delivered pursuant to this agreement.



     During each contract year, the Company is required to spend 5% of net sales
during the immediately preceding year on advertising and promotion.



         Upon termination of this agreement, the Company agrees that neither the
Company's  officers,  directors,  principals nor its shareholders  will during a
period of 5 years from the date of termination  manufacture  Sensors or purchase
Sensors  manufactured  by any entity  other than Scantek for use in the licensed
devices or any competing device or directly or indirectly  manage,  operation or
control  of or be  connected  as an  officer,  director,  shareholder,  partner,
consultant, owner, employee, agent, lender, donor, vendor, or otherwise, or have
any  financial  interest  in or aid  assist  anyone  else in the  conduct of any
competing entity which offers similar devices for sale.



         The Company is required to maintain product liability  insurance with a
limit of not less than $1,000,000.



         Note 4 - Related Party transactions



         a. Issuance of Common Shares



     On September 30, 1997, the Company issued  6,448,606 shares of common stock
to Health Tech in  consideration  for the purchase of certain  patents valued at
$252,500.



         As of the year ending December 31, 1999, Mr. Roger Fidler was President
of both the Company and of Health Tech.



         On September  30, 1997,  the Company  sold  2,000,000  shares of common
stock to Scantek Medical, Inc. ("Scantek") pursuant to Regulation D for $2,000.





         b. Lease Commitment



     The Company  occupies  office  space on a month to month basis for $250 per
month from Roger Fidler, President, at 400 Grove Street, Glen Rock, New Jersey.



         c. Officer Salaries



         Roger Fidler, President receives a salary of $500 per month.



         Note 5 - Capital Stock



         a. Common Stock



                On January 30,  1990,  the Company  amended its  certificate  of
incorporation to change its name to D-Lanz  Development  Group,  Inc. and change
the  aggregate  number of shares of stock the Company  may issue to  100,000,000
shares of which 50,000,000 are shares of common stock, $.001 par value per share
and 50,000,000 shares preferred stock, $.001 par value per share.



         b. Issuance of Common Stock



         In May, 1998, the Company filed an Registration  Statement on Form S-8,
issuing an  aggregate  of 300,000  shares of common  stock as  follows:  150,000
shares of common stock to Sound Capital and 150,000 to Thurcon Capital, Inc. The
Company  issued an aggregate of 100,000  shares of common stock  pursuant to the
agreement for financial consulting services valued at $1,000 or $.001 per share.



         On August 14, 1998,  the Company  issued 200,000 shares of common stock
to Joel Brownstein in consideration  for consulting  services valued at $136,000
or $0.68 per share.



         On August 25, 1998,  the Company  issued 400,000 shares of common stock
to Vescom  Holdings,  Inc. in  consideration  for consulting  services valued at
$249,000 or $.623 per share.



         On August 26, 1998,  the Company  issued 200,000 shares of common stock
to Vescom Holdings,  Inc.  pursuant to an agreement for sale for an aggregate of
$200,000 or $1.00 per share.



         On August 26, 1998,  the Company sold 400,000 shares of common stock to
Wharton Capital Corp., ("Wharton") for an aggregate consideration of $200,000 in
consulting fees or $0.40 per share.  As of December 31, 1998,  these shares were
held in escrow by the  Company  pending  immediate  delivery  as  required  by a
purchase option agreement. These shares have not been reflected in the number of
shares of common stock outstanding as of December 31, 1998 and were subsequently
cancelled by the Company in 1999.



         On August 26, 1998,  the Company sold 600,000 shares of common stock at
$1.00 per share in consideration  for notes receivable  aggregating  $600,000 as
follows: 500,000 shares to Joel Brownstein for $500,000; 100,000 shares to Sarit
Hirschkorn (wife of Jay Hait, Esq., Secretary to the Company).



         On December 4, 1998, the consulting agreement with Sarit Hirschkorn was
terminated along with the note receivable for $100,000 plus accrued interest and
has agreed to return the shares of common stock to the Company for cancellation.



         On February 1, 1999,  the Company  entered into a consulting  agreement
with JB for financial  consulting  services to be rendered to the Company over a
three  month  period in  consideration  for  forgiveness  of the  $228,500  note
receivable and accrued interest beginning February 1, 1999 aggregating $230,785.



         In May,  1999, JB returned for  cancellation  271,500  shares of common
stock.







         On February 19, 1999,  the Company filed an  Registration  Statement on
Form S-8, issuing 200,000 shares of common stock to THE TAXIN NETWORK ("TTN") as
financial consultant for an aggregate consideration of $40,000 or $.20 per share
for a term of four months.



         On March 24, 1999, the Company filed an Registration  Statement on Form
S-8,  issuing  400,000  shares of common  stock to Jim D. Tilton  ("Tilton")  of
Louisville,  Kentucky as financial consultant.  The agreement entitles Tilton to
option to  purchase  400,000  shares of common  stock at $0.01 per share.  These
shares to be issued will be registered  on Form S-8 soon after  execution of the
agreement. The shares were valued at $0.20 per share or $80,000.



         On November 19, 1999,  the Company  terminated  the agreement  with Jim
Tilton by mutual  agreement and the shares of common stock are being held by the
Company for cancellation.



         c. Preferred Stock



         The  Company is  authorized  to issue  50,000,000  shares of  preferred
stock,  $.001 par value per  share.  The board of  directors  of the  Company is
granted  the power to  determine  by  resolution  from  time to time the  power,
preferences,   rights,  qualifications,   restrictions  or  limitations  of  the
preferred stock.



        At December 31, 1999, the number of preferred shares outstanding was -0-


         Note 6 - Income Taxes



                The  Company  provides  for  the  tax  effects  of  transactions
reported in the financial  statements.  The provision if any,  consists of taxes
currently due plus deferred taxes related  primarily to differences  between the
basis of assets and  liabilities  for  financial and income tax  reporting.  The
deferred  tax assets and  liabilities,  if any  represent  the future tax return
consequences  of those  differences,  which will either be taxable or deductible
when the assets and  liabilities  are  recovered or settled.  As of December 31,
1999, the Company had no material current tax liability, deferred tax assets, or
liabilities to impact on the Company's  financial  position because the deferred
tax asset  related to the  Company's  net  operating  loss carry forward and was
fully offset by a valuation allowance.



         At December 31, 1999, the Company has net operating loss carry forwards
for income tax purposes of $1,269,949.  These carry forward losses are available
to offset  future  taxable  income,  if any,  and expire in the year  2010.  The
Company's  utilization  of this carry forward  against future taxable income may
become subject to an annual  limitation due to a cumulative  change in ownership
of the Company of more than 50 percent.



         The  components  of the net  deferred tax asset as of December 31, 1999
are as follows:



          Deferred tax asset:

          Net operating loss carry forward                  $  431,783

          Valuation allowance                               $( 431,783)
                                                            ----------

          Net deferred tax asset                               $   -0-



         The Company recognized no income tax benefit for the loss generated for
the SFAS No. 109 requires  that a valuation  allowance be provided if it is more
likely year ended December 31, 1999.



         SFAS No. 109 requires  that a valuation  allowance be provided if it is
more likely than not that some  portion or all of a deferred  tax asset will not
be realized.  The Company's ability to realize benefit of its deferred tax asset
will depend on the generation of future taxable income.  Because the Company has
yet to recognize significant revenue from the sale of its products,  the Company
believes that a full valuation allowance should be provided




         Note 7 -  Commitments and Contingencies



         a. Financial Consulting Agreements



         In May, 1998, the Company filed an Registration  Statement on Form S-8,
issuing an  aggregate  of 300,000  shares of common  stock as  follows:  150,000
shares of common stock to Sound Capital and 150,000 to Thurcon Capital, Inc.



         The  Company  issued an  aggregate  of 100,000  shares of common  stock
pursuant to the agreement for financial  consulting services valued at $1,000 or
$.001 per share.



         b. Agreement with Joel Brownstein



         In August,  1998, the Company filed an  Registration  Statement on Form
S-8,  registering  options to sell  200,000  shares of common stock at $.001 per
share for an aggregate of $2,000 to Joel Brownstein  ("JB") in consideration for
a financial  consulting  agreement for a period of 6 months.  On August 5, 1998,
the Company  issued the shares of common stock.  The  transaction  was valued at
valued at $136,000 or $0.68 per share.



         On December 1, 1998, the Company  restructured its note receivable with
Joel Brownstein ("JB") in consideration for the sale of 500,000 shares of common
stock as follows:  A new note for $228,500  with interest at 6% due by March 31,
1999 was entered into and an agreement to return  271,500 shares of common stock
as soon as practical for cancellation.



         On February 1, 1999,  the Company  entered into a consulting  agreement
with JB for financial  consulting  services to be rendered to the Company over a
three  month  period in  consideration  for  forgiveness  of the  $228,500  note
receivable and accrued interest to February 1, 1999 aggregating $230,785.









         c. Agreement with Wharton Capital Corp.



         On August 13, 1998,  the Company  entered  into a financial  consulting
agreement with Wharton  Capital Group,  Inc.  ("Wharton") for a term of one year
and may be canceled upon 30 days notice by either party. As  consideration,  the
Company  issued  400,000  shares of common  stock  valued  in the  aggregate  at
$249,000 or $.62 per share.



         d. Agreement with Vescom Holdings, Inc.



         On August 25, 1998, the Company entered into a financial and management
consulting  agreement  with Vescom  Holdings,  Inc. for a period of one year. In
consideration  for this  agreement,  the  Company  agreed to as  follows:  issue
400,000  shares of common  stock  valued at $4,000 or $.01 per  share;  to grant
options  to  purchase  200,000  shares  of  common  stock at $1.00 per share and
required the payment of an aggregate of $100,000. The payment of $100,000 was to
be paid in  installments  as follows:  $25,000 upon  execution of the  contract;
$25,000;  $25,000 a week  latter and the  balance  within 30 days  provided  the
Company is satisfy with Vescom's performance.



     As of December 31, 1998, 200,000 of the 400,000 shares of common stock were
delivered and the initial payment of $25,000 was made.



         As of December 31, 1998,  the contract was canceled for  unsatisfactory
performance.



         As of December  31, 1998,  200,000  shares were being held in escrow by
the  Company  pending  immediate  delivery  as  required  by a  purchase  option
agreement.  These  shares  have not been  reflected  in the  number of shares of
common stock outstanding as of December 31, 1998.



          As of December 31,  1999,  these shares were being held by the Company
for cancellation for non-execution of the agreement for optioned shares at $1.00
per share.





         e. Agreement with Sarit Hirschkorn



         On August 23,  1998,  the  Company  entered  into  computer  consulting
agreement with Sarit  Hirschkorn  ("Hirschkorn")  to create a customer and sales
tracking database.  In consideration for these services,  Hirschkorn was granted
an option to  purchase  100,000  shares of common  stock at $1.00 per share.  In
August, 1998, the Company issued 100,000 shares of common stock in consideration
for a note receivable for $100,000 plus accrued interest at 6%.



         On December 4, 1998, the agreement was  terminated  along with the note
receivable  for  $100,000  plus  accrued  interest  and has agreed to return the
shares of common stock to the Company for cancellation.



         f. Agreement with THE TAXIN NETWORK



          On February 19, 1999, the Company filed an  Registration  Statement on
Form S-8, issuing 200,000 shares of common stock to THE TAXIN NETWORK ("TTN") as
financial consultant for an aggregate consideration of $40,000 or $.20 per share
for a term of four months.



         The agreement  calls for members of the Company to make  appearances on
various  broadcast  stations around the country,  optional mailings to a list of
listeners of "The Financial Hours with Ed Taxin";  printing of press releases to
be  published  on the  Internet  under  the by line Ed Taxin;  inclusion  of the
Company  at various  speaking  engagements  and  financial  seminars  ;and other
appearance opportunities.



         g. Agreement with Jim D. Tilton

         On March 24, 1999, the Company filed an Registration  Statement on Form
S-8,  issuing  400,000  shares of common  stock to Jim D. Tilton  ("Tilton")  of
Louisville,  Kentucky as financial consultant.  The agreement entitles Tilton to
option to  purchase  400,000  shares of common  stock at $0.01 per share.  These
shares to be issued will be registered  on Form S-8 soon after  execution of the
agreement.

         This Agreement was terminated on______________________



         Note 8 - Development Stage Company



                The Company is considered to be a development stage company with
little  operating  history.  The Company is dependent  upon the resources of the
Company's  management  and its  ability to raise or borrow  additional  funds to
continue to exist.  The Company has purchased the License  rights to manufacture
and  market  certain  patented   technologies  from  Scantek  and  will  require
additional  funds to complete the process of building  manufacturing  facilities
and implement the Company's marketing program.



         Note 9 - Subsequent Events



              Subsequent  to the date of the financial  statements,  the Company
formed a  subsidiary  with the name Global  Agri-Med  Technologies,  Inc. and on
March 31, 2000  assigned the License  rights to certain  patented  technology to
manufacture  and market for the  countries of Chile and  Singapore a temperature
sensing  device and  diagnostic  direct  reading,  digital  device to screen the
breast for abnormalities, including cancer.



<PAGE>






















                                   SIGNATURES

                  Pursuant  to the  requirements  of  Section 13 or 15(d) of the
Securities  Exchange Act of 1934,  the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.


DATE:  May 5, 2000                  By:  s/Paul Lambert
                                       --------------------------
                                           Paul Lambert

                                          President & Chief Financial
                                         and Accounting Officer


DATE:  May 5, 2000                  By:  s/     Henry Choi
                                       --------------------------
                                             Henry Choi
                                            Chief Financial
                                            and Accounting Officer

                  Pursuant to the requirements of the Securities Exchange Act of
1934,  this report has been signed below by the  following  persons on behalf of
the registrant and in the capacities and dates indicated.


DATE:  May 5, 2000                  By:  s/Paul Lambert
                                       --------------------------
                                          Paul Lambert
                                          President
                                          Director